Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is use...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 6, 2025